未登录

D

Daniel L. Adams

creatv microtech, inc.

H指数:18

被引数:1,469

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Phenotyping and Clinical Utility of Phagocytic Polyploid Giant Cancer Macrophages in Blood

吞噬多核巨癌细胞巨噬细胞的表型分析与临床应用

IF10.1

2025-09-030

PREAI

Results of a phase I/IIa trial of SV-BR-1-GM inoculation with low-dose cyclophosphamide and interferon alpha (Bria-IMT) in metastatic breast cancer

HUMAN VACCINES & IMMUNOTHERAPEUTICS

IF3.5

2024-08-200

OAAI

Phase I/II study of pembrolizumab in combination with oral binimetinib in patients with unresectable locally advanced or metastatic triple-negative breast cancer

CANCER RESEARCH

IF16.6

2024-05-020

PRE

Monitoring prostate specific membrane antigen or androgen receptor expression on circulating stromal cells in advanced prostate cancer patients and their correlation with patient response

CANCER RESEARCH

IF16.6

2024-03-220

PRE

Identifying and stratifying circulating tumor cell cluster subtypes in metastatic breast cancer patients and evaluating their clinical outcomes

CANCER RESEARCH

IF16.6

2024-03-220

PRE

Circulating cancer-associated macrophage-like cells and macrophage-related cytokines in obese patients with advanced breast cancer who undergo neoadjuvant chemotherapy

JOURNAL OF CANCER

IF3.2

2024-01-010

OAAI

Cancer associated macrophage-like cells in metastatic renal cell carcinoma predicts for poor prognosis and tracks treatment response in real time

SCIENTIFIC REPORTS

IF3.9

2023-06-292

OAAI

PD-L1 Expression on Circulating Antigen Presenting Macrophages in Blood Predicts PFS & OS in an Array of Metastatic Cancer Types Treated with PD-L1/PD-1 Immunotherapies

JOURNAL OF IMMUNOLOGY

IF3.4

2023-05-010

OA

Micronuclei in circulating stromal cells correlates with PD-L1 expression and predicts progression in metastatic breast cancer

CANCER RESEARCH

IF16.6

2023-04-040

PRE

Extracellular vesicles budding from stromal macrophages in the blood of metastatic non-small cell lung cancer patients correlates with poor survival

CANCER RESEARCH

IF16.6

2023-04-040

PRE

Tumor macrophage fusion cells detected in the circulation of metastatic breast cancer patients is prognostic for rapid progression and death

CANCER RESEARCH

IF16.6

2023-04-040

PRE

Peripheral blood biomarkers in Phase II study of pembrolizumab in combination with oral binimetinib in patients with unresectable locally advanced or metastatic triple-negative breast cancer

CANCER RESEARCH

IF16.6

2023-04-040

PRE

Decreases in Circulating Tumor Associated Cells Predicts PFS and OS In A Pooled Analysis Of Phase I Clinical Trials Using SV-BR-1-GM Therapy With Or Without Immune Check-Point Inhibitors In Metastatic Breast Cancer Patients

CANCER RESEARCH

IF16.6

2023-03-010

PRE

Micronuclei in Circulating Tumor Associated Macrophages Predicts Progression in Advanced Colorectal Cancer

IF3.9

2022-11-112

OAAI

CCR5 activation and endocytosis in circulating tumor-derived cells isolated from the blood of breast cancer patients provide information about clinical outcome

BREAST CANCER RESEARCH

IF5.6

2022-05-2312

OAAI

Clinical Applications of Cancer-Associated Cells Present in the Blood of Cancer Patients

IF3.9

2022-03-0211

OAAI

Giant Circulating Cancer-Associated Macrophage-Like Cells Are Associated With Disease Recurrence and Survival in NoneSmall-Cell Lung Cancer Treated With Chemoradiation and Atezolizumab

CLINICAL LUNG CANCER

IF3.3

2021-05-0127

OAAI

Circulating stromal cells in resectable pancreatic cancer correlates to pathological stage and predicts for poor clinical outcomes

NPJ PRECISION ONCOLOGY

IF8

2021-03-1915

OAAI

Cancer associated macrophage-like cells and prognosis of esophageal cancer after chemoradiation therapy

JOURNAL OF TRANSLATIONAL MEDICINE

IF7.5

2020-11-0426

OAAI

Circulating stromal cells in resectable pancreatic cancer is associated with high pathological stage and poor clinical outcomes

CANCER RESEARCH

IF16.6

2020-08-150

PRE